Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

TherapeuticsMD Inc. buy marge

Start price
€129.23
19.08.19 / 50%
Target price
€350.00
04.11.21
Performance (%)
-74.85%
End price
€32.50
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €32.50. The BUY prediction by marge for TherapeuticsMD Inc. performed very badly with a performance of -74.85%. marge has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
TherapeuticsMD Inc. -0.971% -0.971% -36.250% -96.483%
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by marge for this prediction

In the thread Therapeuticsmd Inc. diskutieren
Prediction Buy
Perf. (%) -74.85%
Target price 7.000
Change
Ends at 04.11.21

Buy mit Kursziel 7,0

This  small cap healthcare concerns seeing significant and recent insider buying here during the dog days of summer. Six insiders picked up just under $400K in new shares in aggregate between August 9th and August 15th.  This follows two director buys in May totaling just over $100,000.  Those were the first insider buys since August of 2018 and came after months of frequent and substantial insider selling by numerous insiders.
Canacord Genuity reiterated their Buy rating and $13 price target on TXMD last week.  Immediately after second quarter results, Northland Securities maintained their Buy rating and identical $13 price target on Therapeutics MD.   

In the thread Trading Therapeuticsmd Inc.
Prediction Buy
Perf. (%) -74.85%
Target price 7.000
Change
Ends at 04.11.21

Die von marge gewählte maximale Laufzeit wurde überschritten